A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Artivion, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 5,900 shares of AORT stock, worth $169,389. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,900
Previous 18,000 67.22%
Holding current value
$169,389
Previous $380,000 60.26%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$19.62 - $25.65 $1.23 Million - $1.61 Million
-62,899 Reduced 57.88%
45,766 $1.17 Million
Q1 2024

May 15, 2024

BUY
$16.7 - $21.63 $818,283 - $1.06 Million
48,999 Added 82.12%
108,665 $2.3 Million
Q4 2023

Feb 14, 2024

SELL
$12.33 - $18.83 $34,893 - $53,288
-2,830 Reduced 4.53%
59,666 $1.07 Million
Q3 2023

Nov 14, 2023

SELL
$14.82 - $17.52 $444,007 - $524,899
-29,960 Reduced 32.4%
62,496 $947,000
Q2 2023

Aug 14, 2023

BUY
$12.78 - $17.23 $658,936 - $888,378
51,560 Added 126.08%
92,456 $1.59 Million
Q1 2023

May 15, 2023

SELL
$11.74 - $14.12 $1.67 Million - $2.01 Million
-142,633 Reduced 77.72%
40,896 $535,000
Q4 2022

Feb 14, 2023

BUY
$10.01 - $13.9 $966,415 - $1.34 Million
96,545 Added 110.99%
183,529 $2.22 Million
Q3 2022

Nov 14, 2022

BUY
$13.31 - $23.25 $782,734 - $1.37 Million
58,808 Added 208.72%
86,984 $1.2 Million
Q2 2022

Aug 15, 2022

BUY
$15.73 - $22.91 $42,140 - $61,375
2,679 Added 10.51%
28,176 $532,000
Q1 2022

May 16, 2022

SELL
$16.95 - $21.74 $421,190 - $540,217
-24,849 Reduced 49.36%
25,497 $545,000
Q4 2021

Feb 14, 2022

SELL
$17.19 - $22.84 $756,910 - $1.01 Million
-44,032 Reduced 46.65%
50,346 $1.02 Million
Q3 2021

Nov 15, 2021

BUY
$22.29 - $28.7 $821,609 - $1.06 Million
36,860 Added 64.08%
94,378 $2.1 Million
Q2 2021

Aug 16, 2021

BUY
$22.32 - $32.07 $713,748 - $1.03 Million
31,978 Added 125.21%
57,518 $1.63 Million
Q4 2020

Feb 16, 2021

SELL
$16.76 - $23.74 $3.03 Million - $4.29 Million
-180,537 Reduced 87.61%
25,540 $603,000
Q3 2020

Nov 16, 2020

BUY
$16.35 - $21.4 $2.98 Million - $3.9 Million
182,140 Added 760.91%
206,077 $3.81 Million
Q1 2020

May 15, 2020

SELL
$14.66 - $30.57 $319,969 - $667,220
-21,826 Reduced 47.69%
23,937 $405,000
Q4 2019

Feb 14, 2020

BUY
$22.45 - $27.09 $43,463 - $52,446
1,936 Added 4.42%
45,763 $1.24 Million
Q2 2019

Aug 14, 2019

BUY
$27.55 - $32.39 $986,813 - $1.16 Million
35,819 Added 447.29%
43,827 $1.31 Million
Q1 2019

May 15, 2019

SELL
$25.85 - $30.47 $89,415 - $105,395
-3,459 Reduced 30.16%
8,008 $0
Q4 2018

Feb 14, 2019

SELL
$25.76 - $34.03 $667,158 - $881,342
-25,899 Reduced 69.31%
11,467 $325,000
Q2 2018

Aug 10, 2018

BUY
$19.4 - $29.35 $180,342 - $272,837
9,296 Added 33.12%
37,366 $0
Q1 2018

May 11, 2018

SELL
$16.85 - $22.1 $146,207 - $191,761
-8,677 Reduced 23.61%
28,070 $563,000
Q4 2017

Feb 09, 2018

BUY
$18.65 - $23.85 $685,331 - $876,415
36,747
36,747 $704,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.16B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.